Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
This article explains why benchmark returns can differ from index returns and what this means for investors evaluating results.
26,521 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Two refining giants posted solid Q4 results, signaling a strong 2026 for the sector. The question on investors’ minds...
New projections show the Social Security trust fund could exhaust sooner than expected, prompting a bold plan to rely...
In 2025, holdings' 2025 review: from fintech disruptor to banking powerhouse marks a turning point from rapid scale t...
Shiba Inu’s key on-chain metric has dropped to a five-year low, signaling caution but also a possible setup for a fut...
The Strait of Hormuz has seen traffic grind to a near standstill as conflict escalates, sending ripples through oil p...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
Netflix walks away from an $83 billion Warner Bros. deal, freeing capital for expansion and content, lifting the stoc...
A bitcoin miners ETF posted a dramatic weekly surge, underscoring how mining infrastructure can deliver cash flows ev...
Investors often chase eye-popping targets, but can Nvidia stock truly double in 12 months? This article breaks down t...
A USD EM bond ETF is delivering about 5.4% yield, drawing retirees to its monthly payouts. This piece examines income...
SpaceX reportedly trims its IPO ambitions, signaling a lower target valuation looming. This article breaks down what ...